Definitive Healthcare Corp.

Equities

DH

US24477E1038

Software

Market Closed - Nasdaq 04:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
7.19 USD -1.64% Intraday chart for Definitive Healthcare Corp. -6.99% -27.67%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Definitive Healthcare Introduces Carevoyance Sales Enablement Solution for Medtech Industry CI
Definitive Healthcare Collaborating With VML Health on Key Opinion Leader Management Tool for Clients MT
Definitive Healthcare and VML Health Announce Partnership to Transform Key Opinion Leader Management CI
Deutsche Bank Adjusts Definitive Healthcare Price Target to $10 From $9, Maintains Hold Rating MT
Barclays Adjusts Price Target on Definitive Healthcare to $11 From $10, Maintains Equalweight Rating MT
Definitive Healthcare Seeks Inorganic Growth CI
Transcript : Definitive Healthcare Corp., Q4 2023 Earnings Call, Feb 28, 2024
Earnings Flash (DH) DEFINITIVE HEALTHCARE Reports Q4 EPS $0.07, vs. Street Est of $0.08 MT
Earnings Flash (DH) DEFINITIVE HEALTHCARE Posts Q4 Revenue $65.9M, vs. Street Est of $66M MT
Definitive Healthcare Corp. Provides Earnings Guidance for the First Quarter CI
Definitive Healthcare Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Definitive Healthcare Corp. (NasdaqGS:DH) acquired Carevoyance business line of H1 Insights, Inc for $14 million. CI
North American Morning Briefing : TSMC Results -2- DJ
Definitive Healthcare Shares Drop After Downgrade From Needham MT
Stifel Adjusts Definitive Healthcare's Price Target to $11 From $12, Keeps Buy Rating MT
Needham Downgrades Definitive Healthcare to Hold From Buy MT
Definitive Healthcare Says Musslewhite Steps Down as CEO; Founder Krantz Named in Interim; 2024 Guidance Set MT
Definitive Healthcare Corp. Announces Resignation of Robert Musslewhite as Member of the Board of Directors CI
Definitive Healthcare Corp. Announces Chief Executive Officer Changes CI
Definitive Healthcare Corp. Reaffirms Earnings Guidance for the Fourth Quarter 2023 and Provides Earnings Guidance for the Full Year 2024 CI
North American Morning Briefing : Boeing Drags -2- DJ
Canaccord Genuity Downgrades Definitive Healthcare to Hold From Buy, Price Target is $10 MT
Definitive Healthcare Plans to Cut Workforce by 154 People MT
Barclays Raises Definitive Healthcare Price Target to $10 From $7, Maintains Equal Weight Rating MT
Deutsche Bank Cuts Definitive Healthcare Price Target to $9 From $14, Maintains Hold rating MT
Chart Definitive Healthcare Corp.
More charts
Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. All of its business is conducted through AIDH TopCo, LLC (Definitive OpCo).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7.19 USD
Average target price
10.4 USD
Spread / Average Target
+44.65%
Consensus
  1. Stock Market
  2. Equities
  3. DH Stock
  4. News Definitive Healthcare Corp.
  5. Credit Suisse Cuts Definitive Healthcare's PT to $19 From $24, Says Macro Continues to Slow Decision Making; Keeps Neutral Rating